I recently attended a conference on regenerative medicine In Washington, D.C., as a guest of Aldevron, a biotechnology firm based in Fargo. Aldevron makes high-quality plasmid DNA and other biological products used in groundbreaking health science. In March 2018, I was given a new treatment for lymphoma based on this revolutionary new science and am alive today because of it.
Companies at the conference are developing and bringing to health care providers and patients new cellular-based products that have the potential to save lives by addressing illnesses such as lymphoma, muscular dystrophy and retinal blindness in children.
Great progress is being made such that in private meetings with North Dakota's Sen. Kevin Cramer, Sen John Hoeven's personal assistant, and Rep. Kelly Armstrong, they expressed strong interest in seeing this development continue with government support. Their thoughtfulness and caring made me proud to have such excellent representatives in Washington.